Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Pharmacodynamics and Pharmacokinetics of Ublituximab Compared with Other Anti-Cd20 Monoclonal Antibodies for Multiple Sclerosis Treatment
Monica Margoni, Luca Battistini, Diego Centonze, Roberto Furlan, Claudio Gasperini, Massimo Filippi (2025). Pharmacodynamics and Pharmacokinetics of Ublituximab Compared with Other Anti-Cd20 Monoclonal Antibodies for Multiple Sclerosis Treatment. , 23, DOI: https://doi.org/10.2174/011570159x392955250815095236.
Article21 days agoPersonalized therapy in multiple sclerosis: an Italian Delphi consensus
Claudio Gasperini, Diego Centonze, Antonella Conte, Paolo Gallo, Alessandra Lugaresi, Francesco Patti, María Trojano, Maria Pia Amato, Massimo Filippi (2025). Personalized therapy in multiple sclerosis: an Italian Delphi consensus. , 272(6), DOI: https://doi.org/10.1007/s00415-025-13173-2.
Article21 days agoPotential use of the SARS-CoV-2 monoclonal antibody sipavibart in people with multiple sclerosis: definition of different patient archetypes from an Italian expert group perspective
Chiara Zanetta, Claudio Gasperini, Maria Pia Amato, Diego Centonze, Paolo Gallo, F. Patti, Agostino Riva, Massimo Filippi (2025). Potential use of the SARS-CoV-2 monoclonal antibody sipavibart in people with multiple sclerosis: definition of different patient archetypes from an Italian expert group perspective. , 272(7), DOI: https://doi.org/10.1007/s00415-025-13188-9.
Article21 days agoThe use of high-efficacy disease-modifying therapies in multiple sclerosis: recommendations from an expert Delphi consensus
Massimo Filippi, Maria Pia Amato, Diego Centonze, Paolo Gallo, Claudio Gasperini, Matilde Inglese, Francesco Patti, Carlo Pozzilli, Paolo Preziosa, María Trojano (2025). The use of high-efficacy disease-modifying therapies in multiple sclerosis: recommendations from an expert Delphi consensus. , 272(9), DOI: https://doi.org/10.1007/s00415-025-13293-9.
Article21 days agoCorrection to: Moving towards a new era for the treatment of neuromyelitis optica spectrum disorders
Paolo Preziosa, Maria Pia Amato, Luca Battistini, Marco Capobianco, Diego Centonze, Eleonora Cocco, Antonella Conte, Claudio Gasperini, Matteo Gastaldi, Carla Tortorella, Massimo Filippi (2024). Correction to: Moving towards a new era for the treatment of neuromyelitis optica spectrum disorders. , 271 (10), DOI: https://doi.org/10.1007/s00415-024-12628-2.
Corrigendum21 days ago